A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors

BACKGROUND: Liposomes are drug nano-carriers that are capable of targeting therapeutics to tumor sites because of enhanced permeability retention (EPR). In several preclinical studies with various tumor-bearing mice models, (188)Re-liposome that has been developed by the Institute of Nuclear Energy...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:EJNMMI Res
मुख्य लेखकों: Wang, Shyh-Jen, Huang, Wen-Sheng, Chuang, Chi-Mu, Chang, Chih-Hsien, Lee, Te-Wei, Ting, Gann, Chen, Ming-Huang, Chang, Peter Mu-Hsin, Chao, Ta-Chung, Teng, Hao-Wei, Chao, Yee, Chen, Yuh-Min, Lin, Tzu-Ping, Chang, Ya-Jen, Chen, Su-Jung, Huang, Yuan-Ruei, Lan, Keng-Li
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Berlin Heidelberg 2019
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531516/
https://ncbi.nlm.nih.gov/pubmed/31119414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0509-6
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन